Predictive variables detailing the recurrence rate of soft tissue sarcomas

Area of Science:

• Oncology
• Surgical Oncology
• Cancer Research

Background:

• Prognostic variables are essential for patient counseling, adjuvant therapy selection, clinical trial stratification, and treatment goal setting in soft tissue sarcoma (STS).
• Established prognostic factors for STS address local recurrence, distant recurrence, disease-specific survival, and overall survival.
• These significant prognostic variables demonstrate both site-dependent and time-dependent characteristics.

Purpose of the Study:

• To review the established prognostic variables for soft tissue sarcoma.
• To introduce a novel nomogram for predicting sarcoma-specific survival.
• To highlight emerging areas in STS outcome prediction.

Main Methods:

• Review of established prognostic factors in soft tissue sarcoma literature.
• Description of a recently developed nomogram incorporating tumor size, grade, histology, depth, and patient age.
• Identification of emerging prognostic indicators such as response to neoadjuvant chemotherapy and molecular markers.

Main Results:

• Prognostic variables for local recurrence, distant recurrence, disease-specific survival, and overall survival have been defined for soft tissue sarcoma.
• A nomogram predicting 12-year sarcoma-specific survival at diagnosis, considering tumor characteristics and patient age, has been developed.
• Response to neoadjuvant chemotherapy and molecular markers are identified as emerging areas for outcome prediction.

Conclusions:

• Understanding prognostic variables is critical for optimizing patient management and clinical trial design in soft tissue sarcoma.
• The newly developed nomogram provides a valuable tool for predicting long-term survival in STS patients at diagnosis.
• Further research into neoadjuvant chemotherapy response and molecular markers holds promise for refining prognostic accuracy in soft tissue sarcoma.